Overview Of Polycystic Ovary Syndrome (PCOS)
Department of Pharmacology, NRI College of pharmacy, Agiripalli, Krishna, Andhra Pradesh, India.
Review
World Journal of Advanced Engineering Technology and Sciences, 2023, 08(02), 011–022.
Article DOI: 10.30574/wjaets.2023.8.2.0052
Publication history:
Received on 07 January 2023; revised on 22 February 2023; accepted on 25 February 2023
Abstract:
PCOS, commonly known as hyperandrogenic anovulation, is a condition that affects women's ovaries. A frequent endocrine system illness that affects women of reproductive age is polycystic ovarian syndrome (PCOS), also known as hyperandrogenic anovulation (HA), or Stein-Leventhal syndrome (Evans and Riley, 1958). According to Stein and Leventhal (1935), it is a condition that develops on one or both ovaries when an estimated 10 tiny cysts with a diameter ranging from 2 to 9 mm and/or an ovarian volume greater than 10 ml are present. According to a systematic examination of women using National Institutes of Health (NIH) diagnostic criteria, 4–10% of women of reproductive age have PCOS. Recent research reveals that PCOS is a lifelong syndrome that first manifests during pregnancy, despite the fact that it was traditionally thought to be a disorder that only affected adult women. It is a syndrome that can be avoided by raising awareness among patients and healthcare professionals. Starting with its diagnosis, pathophysiology, repercussions, and treatment options, there are numerous areas of disagreement(1).
Keywords:
Cyst; Pregnancy; Oestrogen; Hypothalamus; Insulin; Puberty
Full text article in PDF:
Copyright information:
Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0